By MICHAEL L. MILLENSON Three government experts on a health tech conference panel discuss the urgency of releasing actionable data; all are women. A more senior official, another woman, gives a TED-style talk making the same case. And a four-person, private-sector panel debates privacy and ethics; three of the four are female. Health Datapalooza, a… Read More »
An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a disease that can affect multiple organs, with a drug approved for rheumatoid arthritis. Successful treatment of two other patients with similarly severe disease suggests an effective treatment for an incurable, sometimes life-threatening illness is within reach. The research was published in the… Read More »
As Canada edged ever closer this year to making it legal for any adult to buy marijuana, Dr. Hance Clarke noticed a surprising phenomenon. At his Toronto pain clinic, Clarke encountered more and more people eager for him to prescribe medical cannabis, though they could soon buy the drug without anyone’s approval. The trend has… Read More »
Nearly 10 million people around the world will die of cancer this year, according to new estimates from the World Health Organization’s International Agency for Research on Cancer (IARC). The IARC’s report, which was published Wednesday in CA: A Cancer Journal for Clinicians, was based on cancer incidence data from 185 countries around the world.… Read More »
Do you know that many arthritis medications are available to match the many types of arthritis in existence? Although it may not be easy to name the various arthritis pain medications, listed here are among the 4 commonly used as well as effective ones: Analgesics (Pain-killer), Disease-Modifying Antirheumatic Drugs (DMARD), Fibromyalgia medications, and Osteoporosis medications.… Read More »